NEW YORK (GenomeWeb News) – PerkinElmer has licensed photon detection technology developed by the Max Planck Institute for use in a range of molecular imaging applications, the Waltham, Mass.-based company said today.

Under the exclusive agreement with Max Planck Innovation, the Max Planck Institute's technology transfer arm, the company has licensed solid state silicon photomultiplier, or SiPM, technology that it will use in clinical diagnostics, as well as molecular detection and analytical applications, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.